- Home
- SPAI vs ONCO Comparison
SPAI vs ONCO Comparison
Compare SPAI & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPAI
- ONCO
- Stock Information
- Founded
- SPAI 2021
- ONCO 2018
- Country
- SPAI United States
- ONCO United States
- Employees
- SPAI N/A
- ONCO N/A
- Industry
- SPAI Industrial Specialties
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- SPAI Health Care
- ONCO Health Care
- Exchange
- SPAI Nasdaq
- ONCO Nasdaq
- Market Cap
- SPAI 27.1M
- ONCO 24.1M
- IPO Year
- SPAI 2024
- ONCO 2022
- Fundamental
- Price
- SPAI $4.47
- ONCO $1.13
- Analyst Decision
- SPAI
- ONCO
- Analyst Count
- SPAI 0
- ONCO 0
- Target Price
- SPAI N/A
- ONCO N/A
- AVG Volume (30 Days)
- SPAI 4.7M
- ONCO 72.7K
- Earning Date
- SPAI 11-14-2024
- ONCO 12-03-2024
- Dividend Yield
- SPAI N/A
- ONCO N/A
- EPS Growth
- SPAI N/A
- ONCO N/A
- EPS
- SPAI N/A
- ONCO N/A
- Revenue
- SPAI $1,559,057.00
- ONCO $1,463,746.00
- Revenue This Year
- SPAI N/A
- ONCO N/A
- Revenue Next Year
- SPAI N/A
- ONCO N/A
- P/E Ratio
- SPAI N/A
- ONCO N/A
- Revenue Growth
- SPAI 35.50
- ONCO N/A
- 52 Week Low
- SPAI $1.56
- ONCO $1.01
- 52 Week High
- SPAI $6.50
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- SPAI N/A
- ONCO 20.90
- Support Level
- SPAI N/A
- ONCO $1.01
- Resistance Level
- SPAI N/A
- ONCO $1.26
- Average True Range (ATR)
- SPAI 0.00
- ONCO 0.23
- MACD
- SPAI 0.00
- ONCO -0.07
- Stochastic Oscillator
- SPAI 0.00
- ONCO 6.15
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Safe-Pro USA.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.